Medical Oncologist
CION Cancer Clinics
Active surveillance or surgery: how the choice is made | CION Cancer Clinics
Active surveillance means a low-risk prostate cancer is watched closely with PSA tests, MRI scans and repeat biopsies, and treated only if it changes. Surgery means the prostate is removed now. Both are standard options for a contained, low-risk cancer. This page explains what each path involves day to day, what your team weighs before advising, and what it cannot decide for you. CION Cancer Clinics’ surgical oncologists in Hyderabad can talk this through with you.
MI
Medically reviewed by Dr. Mohammed ImaduddinConsultant Surgical Oncologist · MBBS, MS (General Surgery), MCh (Surgical Oncology) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Active surveillance or surgery: what is the real difference?
- How do the two paths compare, day to day?
- What does the team actually weigh before advising?
- What does active surveillance actually involve?
- Four things families tell us, and what is actually true
- What can this page not tell you, and what should you ask?
- Common questions about surveillance and surgery
The short answer
Active surveillance or surgery: what is the real difference?
Active surveillance means the cancer is watched closely with blood tests, scans and repeat biopsies, and treated only if it starts to change. Surgery means the prostate is removed now. Both are standard ways of managing a low-risk prostate cancer. Neither is the brave choice or the careless one.
Why doctors offer watching at all
Many prostate cancers grow very slowly. Removing the prostate has lasting side effects, most often leaking urine and trouble with erections. Surveillance keeps the option of treatment open while avoiding those side effects for as long as the cancer stays quiet. It is not the same as doing nothing.
Why surgery is still chosen
Some men find the waiting harder than the operation. Some have a result that sits at the edge of low risk, so the team is less sure the cancer will stay quiet. Some are young enough that a slow cancer still has decades in which to change. For them, removing the gland while it is contained is a reasonable plan.
This page is for a man who has been told the cancer is low risk and both options are open. If your report says high risk, or that the cancer has spread beyond the prostate, the choices are different.Side by side
How do the two paths compare, day to day?
Active surveillance
Radical prostatectomy
Nothing is removed. The cancer stays in place and is checked regularly
The whole prostate and the seminal vesicles are removed in one operation
No operation, no anaesthetic, no hospital stay
A general anaesthetic, a hospital stay and a catheter for a period afterwards
No effect on urine control or erections from the surveillance itself
Leaking urine and erection problems are common early on and can last
Living with a known cancer inside you, which some men find very hard
The cancer is out, but recovery takes months and side effects can be permanent
Treatment stays possible later if the cancer changes
If anything is left behind, radiation is the usual next step
Behind the recommendation
What does the team actually weigh before advising?
The advice you get is built from your reports and one thing only you can answer.
The Gleason score or grade group
The score the pathologist gives the biopsy cores. It describes how abnormal the cells look and how likely they are to behave aggressively. Surveillance is mainly offered at the lowest grade, and sometimes one step up when other findings are favourable.
The PSA level and how it is moving
PSA is a protein the prostate releases into the blood. One reading matters less than the direction of travel. A level that is low and steady supports watching. A level that keeps climbing pushes the team towards treatment.
What the MRI and biopsy show together
How many cores contained cancer, how much of each core, and whether the MRI shows a clear target all feed in.
Usually also considered
- The size of the prostate
- Any family history of prostate cancer
- Whether a genetic test has been done
Your age, health and your own view
A fit man in his fifties and a man in his late seventies with heart disease get different advice for the same report. Your feelings count too. If living with an untreated cancer would keep you awake every night, the team needs to know.
Bring the family member who will help you decide. This is rarely a one-visit decision.Not sure whether this applies to you?
Ask an oncologistNot doing nothing
What does active surveillance actually involve?
Regular PSA blood tests
A blood test every few months in the first year or two, then less often if the level stays steady. Your team will give you the schedule in writing. A single higher reading is not a trigger on its own; the pattern over time is what matters.
MRI scans of the prostate
A scan at set intervals, or sooner if the PSA moves. The MRI is compared with the earlier one to see whether anything has grown or a new area has appeared. Nothing is injected into the prostate itself.
Repeat biopsies when needed
A biopsy may be repeated after the first year and then when the MRI or PSA gives a reason. Many men find this the least pleasant part. Ask whether the biopsy will be done through the skin rather than the rectum, because that lowers the chance of infection.
A clear trigger for treatment
Before you start, ask what would make the team recommend treatment. A higher grade on a repeat biopsy, a growing area on MRI, or a PSA that keeps climbing are the usual reasons. Knowing the trigger in advance makes the waiting easier to bear.
Commonly believed
Four things families tell us, and what is actually true
"If it is cancer, it has to come out. Waiting is gambling."
For a low-risk prostate cancer, watching closely is a recognised plan in every major guideline. The cancer is tested repeatedly and treatment is offered the moment it changes. The operation carries its own lasting costs, which is why doctors do not rush every man into it.
"Surveillance is what they offer when they have given up."
The opposite. Surveillance is offered when the team thinks the cancer is slow enough that treatment can safely wait. It is a plan with a schedule, a trigger and a doctor in charge. Men too unwell for treatment are managed differently, with watchful waiting.
"If he has the operation, the cancer is dealt with once and for all."
Surgery removes the gland, and for contained disease that is often the end of it. But PSA is still checked for years, and some men need radiation later if it rises. No option on this page closes the door on follow-up.
"He is too old for surgery, so watching is the only choice."
Age alone does not decide it. Fitness, other illnesses and how long the cancer would have to change matter more than the number on a birth certificate. Some men in their seventies are offered surgery; some in their sixties are advised to watch.
Being straight with you
What can this page not tell you, and what should you ask?
This page cannot tell you whether your cancer is safe to watch. That depends on the grade, the PSA, the MRI and the biopsy together, read by a team who has seen them all. It also cannot tell you how you will feel living with either choice, and that matters more than most men expect.
Questions worth asking at the next visit
Ask which risk group your cancer falls into and why. Ask what the surveillance schedule would look like, and what would trigger a change of plan. Ask what surgery would involve for you, including whether nerve-sparing is possible. Ask whether radiation is also an option, because for many men it is a third path between the two.
When a second opinion helps
If one doctor has recommended surgery and another has recommended watching, it usually means your report sits near the line. A tumour board, where surgeons, radiation oncologists and medical oncologists look at the case together, is the fairest way to settle it. Ask whether your case has been through one.
Questions we are asked
Common questions about surveillance and surgery
Will the cancer spread while we are watching it?
The purpose of surveillance is to catch any change before the cancer leaves the prostate. That is why it involves regular PSA tests, MRI scans and repeat biopsies rather than a yearly check. Most low-risk cancers stay quiet, and those that change are usually still treatable when they do.
Can I choose surgery later if I start on surveillance?
Yes. Surveillance is a plan you can leave at any time, either because the tests change or because you decide you would rather have treatment. Tell your team as soon as you feel that way rather than carrying it alone between appointments.
Is radiation a third option?
Often, yes. For localised prostate cancer, radiation is a standard treatment alongside surgery, with a different pattern of side effects. If you have been offered only surgery or surveillance, it is fair to ask why radiation has not been discussed.
How often will I need a biopsy on surveillance?
Schedules vary between centres. A repeat biopsy is often done within the first year or two to confirm the cancer was graded correctly, and after that only when the MRI or PSA gives a reason. Ask your team for the schedule in writing.
My father is seventy-five. Does that settle it?
No. Age is one factor, not the deciding one. A fit man of seventy-five with a low-risk cancer may be advised to watch because the cancer is unlikely to trouble him. The same man with a higher-risk finding may be offered surgery or radiation. His other illnesses and his own wishes carry as much weight as his age.
Does surveillance mean we do not need to see a surgeon?
It is still worth seeing one. A surgical oncologist or urologist can explain what the operation would involve for you, so that if the plan changes you already understand the choice. Surveillance is usually run by the same team that would treat you if needed.
Will surveillance cost less than surgery?
In the short term, usually yes, because there is no operation and no hospital stay. Over years, the repeated scans and biopsies add up, and some men eventually have treatment anyway. Aarogyasri, CGHS, ECHS, EHS and cashless insurance treat the two paths differently, so ask about your own cover first.
What if I simply cannot cope with the waiting?
That is a legitimate reason to choose treatment, and your team will not think less of you for it. Some men find a written schedule and a named contact make the waiting bearable. Others do not, and for them the certainty of treatment is worth its side effects.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- Cancer Research UK — Treatment for prostate cancer
- American Cancer Society — Observation or active surveillance for prostate cancer
- NICE — Prostate cancer: diagnosis and management (NG131)
- National Cancer Institute — Prostate cancer treatment (PDQ) patient version
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Surgery or Radiation for Prostate Cancer?The third path many men are not told aboutRadical Prostatectomy: What the Operation InvolvesWhat surgery would actually mean for youProstatectomy in Older MenWhy age alone does not decide itDeciding on Cancer SurgeryHow to weigh any operation, and the questions to ask
Talk to us
Been offered both and not sure which to choose?
Send us your biopsy and MRI reports or call the helpline. A surgical oncologist will explain which risk group you are in and what each option would mean for you. One helpline serves every CION centre.